Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
61 studies found for:    CHOLANGITIS, PRIMARY SCLEROSING
Show Display Options
Rank Status Study
21 Recruiting Phase 2 Study of NGM282 in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Interventions: Biological: NGM282;   Other: Placebo
22 Unknown  Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Interventions: Procedure: plastic endoprosthesis;   Procedure: balloon dilatation
23 Recruiting Safety, Tolerability, and Efficacy of GS-9674 in Adults With Primary Sclerosing Cholangitis Without Cirrhosis
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: GS-9674;   Drug: Placebo to match GS-9674
24 Completed Trial of High-dose Urso in Primary Sclerosing Cholangitis
Condition: Sclerosing Cholangitis
Intervention: Drug: Ursodeoxycholic Acid
25 Completed Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Subjects With Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Interventions: Biological: Simtuzumab;   Biological: Placebo
26 Active, not recruiting Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Interventions: Drug: OCA;   Drug: Placebo
27 Completed Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Drug: LUM001
28 Recruiting Secondary Sclerosing Cholangitis in Critically Ill Patients
Condition: Secondary Sclerosing Cholangitis
Intervention:
29 Recruiting Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures
Condition: Primary Sclerosing Cholangitis
Intervention: Device: probe based confocal laser endomicroscopy
30 Recruiting Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Conditions: Primary Sclerosing Cholangitis;   Biliary Atresia
Intervention: Drug: Oral Vancomycin
31 Completed
Has Results
Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Conditions: Primary Sclerosing Cholangitis;   Biliary Atresia
Intervention: Drug: Vancomycin
32 Recruiting A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease
Intervention: Drug: Vancomycin
33 Recruiting Genomics of Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Genetic: Genetic Analysis
34 Completed A Pilot Study of Xifaxan to Treat Patients With PSC
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Drug: Xifaxan
35 Unknown  NPD Measurements in PSC Patients
Condition: Primary Sclerosing Cholangitis
Intervention:
36 Terminated
Has Results
Fenofibrate for PSC
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: fenofibrate
37 Recruiting Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis
Conditions: IgG4-related Sclerosing Cholangitis;   IgG4-related Disease
Intervention:
38 Completed Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
Conditions: Primary Sclerosing Cholangitis;   Trisomy 7;   Cholangiocarcinoma;   Chemoprevention
Intervention: Drug: Erlotinib (Tarceva)
39 Completed Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis
Conditions: Ulcerative Colitis;   Primary Sclerosing Cholangitis;   Pouchitis;   Complications
Intervention:
40 Completed Evaluation of DHA for the Treatment of PSC
Conditions: Primary Sclerosing Cholangitis;   Colitis
Intervention: Drug: Docosahexaenoic Acid (DHA)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.